Literature DB >> 9234535

Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination.

J J Donnelly1, A Friedman, J B Ulmer, M A Liu.   

Abstract

Previously we showed that immunization of ferrets with DNA encoding the hemagglutinin (HA), nucleoprotein (NP), and matrix protein (M1) of influenza virus induced protective immune responses. A DNA vaccine encoding HA (from a 1991 strain), NP and M1 (from a 1989 strain) protected ferrets better against challenge with the antigenic drift variant A/Georgia/03/93 than did the inactivated vaccine from the 1992-93 influenza season. Here we report that the same DNA vaccine protected ferrets against a second, further divergent, drift variant (A/Johannesburg/33/94). Furthermore, the extent of protection provided by the DNA vaccine was equivalent to the homologous protection provided by an inactivated vaccine that exactly matched the challenge strain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234535     DOI: 10.1016/s0264-410x(96)00268-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.

Authors:  Wenling Wang; Renqing Li; Yao Deng; Ning Lu; Hong Chen; Xin Meng; Wen Wang; Xiuping Wang; Kexia Yan; Xiangrong Qi; Xiangmin Zhang; Wei Xin; Zhenhua Lu; Xueren Li; Tao Bian; Yingying Gao; Wenjie Tan; Li Ruan
Journal:  Clin Vaccine Immunol       Date:  2015-04-01

Review 2.  Expression library immunization: a road map for discovery of vaccines against infectious diseases.

Authors:  Adel M Talaat; Katherine Stemke-Hale
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 3.  Development of universal influenza vaccines based on influenza virus M and NP genes.

Authors:  M Zheng; J Luo; Z Chen
Journal:  Infection       Date:  2013-11-01       Impact factor: 3.553

Review 4.  Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccines.

Authors:  Andrea Orsi; Filippo Ansaldi; Daniela de Florentiis; Antonella Ceravolo; Valentina Parodi; Paola Canepa; Martina Coppelli; Giancarlo Icardi; Paolo Durando
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

Review 5.  Vaccine approaches conferring cross-protection against influenza viruses.

Authors:  Sai V Vemula; Ekramy E Sayedahmed; Suryaprakash Sambhara; Suresh K Mittal
Journal:  Expert Rev Vaccines       Date:  2017-09-19       Impact factor: 5.217

6.  Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus.

Authors:  Ke Xu; Zhi-Yang Ling; Liang Sun; Ying Xu; Chao Bian; Yuan He; Wei Lu; Ze Chen; Bing Sun
Journal:  Viral Immunol       Date:  2011-02       Impact factor: 2.257

7.  Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.

Authors:  Lu Zhang; Na Jia; Jun Li; Yaping Han; Wuchun Cao; Shixia Wang; Zuhu Huang; Shan Lu
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

8.  Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovis as genetic adjuvant.

Authors:  Babak Jalilian; Abdul Rahman Omar; Mohd Hair Bejo; Noorjahan Banu Alitheen; Mehdi Rasoli; Sohkichi Matsumoto
Journal:  Genet Vaccines Ther       Date:  2010-05-24

9.  Effect of immunization with plasmid DNA encoding for rinderpest virus matrix protein on systemic rinderpest virus infection in rabbits.

Authors:  B Pahar; B Sharma; A C Goel
Journal:  Vet Res Commun       Date:  2002-04       Impact factor: 2.459

10.  Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis.

Authors:  Marcelo Sousa Silva; Duarte Miguel F Prazeres; Andreia Lança; Jorge Atouguia; Gabriel Amaro Monteiro
Journal:  Parasitol Res       Date:  2009-07-07       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.